Personal profile
Fingerprint
Dive into the research topics where Masashi Kondo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
BRAF V600E-mutant squamous cell carcinoma of the lung in patients with a history of papillary thyroid carcinoma: A three-case series
Hashimoto, N., Moriya, R., Akao, K., Kako, H., Goto, Y., Souma, T., Oya, Y., Kondo, Y., Tsukamoto, T., Isogai, S., Kondo, M. & Imaizumi, K., 01-2026, In: Respiratory Investigation. 64, 1, 101344.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy of pembrolizumab plus pemetrexed in older patients with non-squamous NSCLC according to PD-L1 expression status: Results from the CJLSG1901 study
Kogure, Y., Hashimoto, H., Ikeda, S., Harada, T., Hino, A., Miura, S., Goto, Y., Fujiwara, K., Katakami, N., Kubota, K., Murata, N., Mori, M., Abe, T., Saito, A. M., Yamamoto, N., Saka, H. & Kondo, M., 01-2026, In: Cancer Treatment and Research Communications. 46, 101094.Research output: Contribution to journal › Article › peer-review
Open Access -
High diagnostic yield and treatment impact of bronchoscopy in elderly lung cancer patients (≥ 80 years): A single-center retrospective study
Maeda, S., Ina, T., Ota, A., Matsunaga, M., Horiguchi, T., Ikeda, A., Moriya, R., Sato, T., Sawada, C., Oya, Y., Okachi, S., Goto, Y., Isogai, S., Hashimoto, N., Kondo, M. & Imaizumi, K., 01-2026, In: Respiratory Investigation. 64, 1, 101335.Research output: Contribution to journal › Article › peer-review
Open Access -
Advanced machine learning models for prediction of readmission and mortality risks in patients with chronic obstructive pulmonary disease using routine clinical data
Goto, Y., Niwa, D., Shibata, S., Nishimoto, R., Miyata, M., Kanno, T., Washizawa, T., Kondo, M. & Imaizumi, K., 2025, In: Fujita Medical Journal. 11, 3, p. 121-128 8 p.Research output: Contribution to journal › Article › peer-review
-
Efficacy and safety of brigatinib in patients with ALK TKI-naive advanced ALK+ NSCLC: Integrated analysis of the ALTA-1L and J-ALTA trials
Camidge, D. R., Sugawara, S., Kondo, M., Kim, H. R., Ahn, M. J., Yang, J. C. H., Han, J. Y., Hochmair, M. J., Lee, K. H., Delmonte, A., Kudou, K., Asato, T., Hupf, B., Vranceanu, F., Fram, R. J., Ohe, Y. & Popat, S., 03-2025, In: Lung Cancer. 201, 108424.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus)